胃癌筛查内镜最佳间隔:全国队列研究
该研究基于韩国国民保险数据,纳入2010年新诊断胃癌患者26,199例,按末次筛查内镜与诊断内镜间隔分组比较胃癌特异性生存。结果显示间隔≤3年组较>3年组胃癌特异性死亡风险显著降低(HR 0.72,95%CI 0.64-0.80),倾向评分匹配后调整HR为0.71(95%CI 0.62-0.80)。
要点
- 筛查间隔≤3年与>3年相比,胃癌特异性死亡风险显著降低。
- 与从未筛查相比,各筛查间隔组(≤1年至>5年)的胃癌特异性生存HR均低于1。
- 在高风险地区,3年筛查间隔可能是有效策略。
核心结论
- 筛查间隔≤3年的患者较>3年者胃癌特异性死亡风险显著降低。
- 3年筛查间隔可能是高风险地区有效策略。
研究设计与样本
- 基于韩国国民保险索赔数据的全国性队列研究,纳入2010年新诊断胃癌患者26,199例。
- 按末次筛查内镜与诊断内镜间隔分组:≤1年、≤2年、≤3年、≤4年、≤5年、>5年及从未筛查,并进一步分为≤3年和>3年两组,进行倾向评分匹配前后比较。
主要发现
- 与从未筛查组相比,≤1年、≤2年、≤3年、≤4年、≤5年和>5年组的胃癌特异性生存HR分别为0.47、0.34、0.35、0.47、0.44和0.62。
- ≤3年组较>3年组胃癌特异性死亡HR为0.72(95%CI 0.64-0.80)。
- 匹配队列中,≤3年组较>3年组调整HR为0.71(95%CI 0.62-0.80)。
临床怎么用
- 在高风险地区,可考虑将胃癌筛查内镜间隔设为3年以降低胃癌特异性死亡风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: The optimal endoscopic screening interval for gastric cancer (GC) has not yet been established. We compared survival outcomes in patients with GC based on their history of endoscopic screening before diagnosis. METHODS: Using the Korean national insurance claims data, we identified all patients newly diagnosed with GC in 2010. Patients were categorized based on the interval between their last screening endoscopy and diagnostic endoscopy as follows: ≤1 year, ≤2 years, ≤3 years, ≤4 years, ≤5 years, >5 years, and never screened. On the basis of the results of these categories, we further classified the screened patients into 2 groups: ≤3 years and >3 years. We compared the 2 groups before and after propensity score matching. RESULTS: A total of 26,199 patients with GC were included in this study. Compared with the never screened group, the hazard ratios (HRs) for GC-specific survival in the ≤1-year, ≤2-year, ≤3-year, ≤4-year, ≤5-year, and >5-year groups were 0.47, 0.34, 0.35, 0.47, 0.44, and 0.62, respectively. When divided into 2 groups, the ≤3-year group had a significantly lower HR for GC-specific mortality (HR, 0.72; 95% confidence interval [CI], 0.64-0.80) than the >3-year group. In the matched cohort, the adjusted HR was 0.71 (95% CI, 0.62-0.80) in the ≤3-year group compared with the >3-year group. CONCLUSIONS: Patients who underwent screening at intervals ≤3 years had a significantly reduced risk of GC-specific mortality compared with those screened at intervals >3 years. A 3-year screening interval may be an effective strategy for high-risk regions.
引用
- Sung SY, Choi HH, Sin SH, et al. Optimal interval of screening endoscopy for reducing gastric cancer mortality: a nationwide cohort study. Gastrointest Endosc. 2025. PMID: 40835035. doi:10.1016/j.gie.2025.07.051
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。